BCM
GMAB icon

Barometer Capital Management’s Genmab GMAB Stock Holding History

Barometer Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
45,400
+3,000
+7% +$79.7K 0.35% 65
2026
Q1 		$1.14M Buy
42,400
+37,900
+842% +$1.14M 0.39% 63
2025
Q4 		$512K Sell
4,500
-26,437
-85% -$824K 0.12% 99
2025
Q3 		$949K Buy
30,937
+11,800
+62% +$288K 0.22% 67
2025
Q2 		$395K Buy
+19,137
New +$393K 0.11% 110
2024
Q2 		– Sell
-10,337
Closed -$286K – 198
2024
Q1 		$286K Buy
10,337
+6,537
+172% +$192K 0.07% 144
2023
Q4 		$121K Buy
+3,800
New +$119K 0.03% 132

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Barometer Capital Management's GMAB Position: Q2 2026 in Review

Barometer Capital Management increased its Genmab (GMAB) stake by 7.1% in Q2 2026, buying an estimated $79.7K and bringing the position to 45,400 shares worth $1.25M. The position accounts for 0.35% of the portfolio, ranked #65.

Barometer Capital Management first reported a position in GMAB in Q4 2023 and has held it in 7 quarters since. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Barometer Capital Management held 45,400 shares of Genmab worth $1.25M as of Q2 2026.
  • Barometer Capital Management bought 3,000 Genmab shares in Q2 2026, an estimated $79.7K.
  • Genmab made up 0.35% of Barometer Capital Management's portfolio in Q2 2026, its #65 holding.
  • Barometer Capital Management first reported a position in Genmab in Q4 2023 and has held it in 7 quarters since.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Barometer Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.